Xiaoping Qian

1.3k total citations
66 papers, 991 citations indexed

About

Xiaoping Qian is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoping Qian has authored 66 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 21 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoping Qian's work include Colorectal Cancer Treatments and Studies (16 papers), Cancer-related molecular mechanisms research (10 papers) and Gastric Cancer Management and Outcomes (10 papers). Xiaoping Qian is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Cancer-related molecular mechanisms research (10 papers) and Gastric Cancer Management and Outcomes (10 papers). Xiaoping Qian collaborates with scholars based in China, India and Spain. Xiaoping Qian's co-authors include Baorui Liu, Lixia Yu, Jia Wei, Li Xie, Yitao Ding, Zhengyun Zou, Zhibo Hou, Tingting Wang, Jing Hu and Yinzhu Bian and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaoping Qian

62 papers receiving 977 citations

Peers

Countries citing papers authored by Xiaoping Qian

Since Specialization

Citations

This map shows the geographic impact of Xiaoping Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Qian more than expected).

Fields of papers citing papers by Xiaoping Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Qian. The network helps show where Xiaoping Qian may publish in the future.

Co-authorship network of co-authors of Xiaoping Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Qian. A scholar is included among the top collaborators of Xiaoping Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Qian. Xiaoping Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors 2023 ·Advanced Science ·Xinyue Wang, Fanyan Meng, Xiang Li, (unknown), (unknown), (unknown), (unknown), Lin Li, (unknown), (unknown), Zhichen Sun, Yanhong Chu, (unknown), (unknown), Jie Shao, (unknown), Xiaoping Qian, Qin Liu, Baorui Liu, Rutian Li	14
2	1560P Osemitamab (TST001): An ADCC enhanced humanized anti-CLDN18.2 mab, demonstrated improved efficacy in combination with anti-PD-L1/PD-1 mab and oxaliplatin/5-FU in preclinical tumor models 2023 ·Annals of Oncology ·Xiaoping Qian, Fei Teng, Huifang Guo, Xuejing Yao, (unknown), Yujun Wu, (unknown), Yizhuo Gu	3
3	Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (Adv. Sci. 12/2023) 2023 ·Advanced Science ·Xinyue Wang, (unknown), Xiang Li, (unknown), (unknown), (unknown), (unknown), Lin Li, (unknown), Yishan Li, Zhichen Sun, Yanhong Chu, Rui‐Hua Xu, Lixia Yu, Jie Shao, (unknown), Xiaoping Qian, Qin Liu, Baorui Liu, Rutian Li	1
4	SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer 2023 ·Translational Oncology ·Yaping Zhang, Qun Zhang, (unknown), Lu Han, Ting Wang, Jing Hu, Li Li, Ding Zhou, Xiao Shi, Xiaoping Qian	15
5	Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic Cancer 2022 ·Frontiers in Oncology ·Changchang Lu, (unknown), Hao Cheng, Weiwei Kong, (unknown), Lei Wang, Min Tang, Jun Chen, Qi Li, Jian He, Aimei Li, Xin Qiu, Dongsheng Chen, Fanyan Meng, Xiaoping Qian, Baorui Liu, Yudong Qiu, Juan Du	0
6	Tat-HA-NR2B9c attenuate oxaliplatin-induced neuropathic pain 2018 ·Experimental Neurology ·Hai-Hui Zhou, Li Zhang, (unknown), (unknown), Jinping Zhang, Yujie Zhou, Xiaoping Qian, Weihong Ge	19
7	Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancement 2018 ·Cellular Immunology ·Qiuping Xu, Jie Shao, Shu Su, Jia Wei, Fangjun Chen, Fanyan Meng, Yang Zhao, Juan Du, Zhengyun Zou, Xiaoping Qian, Baorui Liu	4
8	FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer 2018 ·Medicine ·(unknown), Li Li, Xiang Zhang, Guangyi Gao, Lili Shen, Jing Hu, Mi Yang, Baorui Liu, Xiaoping Qian	10
9	Engineered cells for costimulatory enhancement combined with IL-21 enhance the generation of PD-1-disrupted CTLs for adoptive immunotherapy 2017 ·Cellular Immunology ·Jie Shao, Qiuping Xu, Shu Su, Fanyan Meng, Zhengyun Zou, Fangjun Chen, Juan Du, Xiaoping Qian, Baorui Liu	7
10	Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway 2016 ·OncoTargets and Therapy ·Jingyu Zhang, Li Xie, Jing Hu, Li Li, Mi Yang, Hua Jiang, Xiaoping Qian, Lei Cheng, Baorui Liu	18
11	On-treatment markers as predictors to guide anti-EGFR MoAb treatment in metastatic colorectal cancer: a systematic review with meta-analysis 2016 ·Cancer Chemotherapy and Pharmacology ·Jing Hu, Zhen Zhang, Rui Zheng, Lei Cheng, Mi Yang, Li Li, Baorui Liu, Xiaoping Qian	6
12	Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma 2015 ·OncoTargets and Therapy ·Xiaoping Qian, Lei Cheng, (unknown), (unknown), Xinyu Bian, (unknown), Qing Wang, Guangchao Li	5
13	Gastric metastasis from sphenoid sinus melanoma: A case report 2014 ·Oncology Letters ·(unknown), Jing Yan, Li Li, Jia Wei, Lin Li, Xiaoping Qian, Baorui Liu, Zhengyun Zou	5
14	Enhancement of Anticancer Efficacy of Chemotherapeutics by Gambogic Acid Against Gastric Cancer Cells 2012 ·Cancer Biotherapy and Radiopharmaceuticals ·Zhengyun Zou, Jia Wei, Xiaolin Li, Lixia Yu, Tingting Wang, Xiaoping Qian, Baorui Liu	16
15	Thymidylate synthase mRNA levels in plasma and tumor as potential predictive biomarkers for raltitrexed sensitivity in gastric cancer 2012 ·International Journal of Cancer ·Jie Shen, Hao Wang, Jia Wei, Lixia Yu, Li Xie, Xiaoping Qian, Zhengyun Zou, Baorui Liu, Wenxian Guan	15
16	Relationship Between Gene Expression of 5-Fluorouracil Metabolic Enzymes and 5-Fluorouracil Sensitivity in Primary Cancer Cells Isolated from Malignant Ascites 2011 ·Cancer Investigation ·Tingting Wang, Lifeng Wang, Xiaoping Qian, Lixia Yu, Yitao Ding, Baorui Liu	8
17	Coamplification at lower denaturation temperature polymerase chain reaction enables selective identification of K-Ras mutations in formalin-fixed, paraffin-embedded tumor tissues without tumor-cell enrichment 2011 ·Human Pathology ·Shaorong Yu, Li Xie, Zhibo Hou, Xiaoping Qian, Lixia Yu, Jia Wei, Yitao Ding, Baorui Liu	1
18	Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions 2010 ·BMC Cancer ·Li Xie, Xi Chen, Lifeng Wang, Xiaoping Qian, Tingting Wang, Jia Wei, Lixia Yu, Yitao Ding, Chen‐Yu Zhang, Baorui Liu	39
19	Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids 2008 ·Cancer Letters ·Baorui Liu, (unknown), Xiaoping Qian, Guangxia Liu, Lixia Yu, Yitao Ding	32
20	ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen 2008 ·British Journal of Cancer ·Jia Wei, Zhengyun Zou, Xiaoping Qian, Yitao Ding, Li Xie, José Javier Sánchez, Yang Zhao, J. Feng, Ling Ye, (unknown), Lixia Yu, Rafael Rosell, (unknown)	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact